WEC Energy Q2 profit rises on cost discipline
Reuters2026/07/29 11:08
Overview
U.S. utility's Q2 net income and EPS rose yr/yr
Consolidated revenue for first half of 2026 increased from prior year
Company reaffirmed 2026 earnings guidance
Outlook
WEC Energy Group reaffirms 2026 earnings guidance of $5.51 to $5.61 per share
Company outlook for 2026 assumes normal weather conditions
Result Drivers
OPERATING EFFICIENCY - Co said focus on customer service, financial discipline and operating efficiency contributed to quarterly results, per CEO Scott Lauber
ELECTRICITY DEMAND MIX - Retail electricity deliveries were essentially flat, with small commercial and industrial use down 0.2%, large commercial and industrial up 0.9%, and residential use down 1.1%
WEATHER-NORMALIZED GROWTH - On a weather-normal basis, retail electricity deliveries rose 1.2% in Q2
Company press release: ID:nPn9DZHFKa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 EPS |
|
$0.91 |
|
Q2 Net Income |
|
$299.20 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 12 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the electric utilities peer group is "buy"
Wall Street's median 12-month price target for WEC Energy Group Inc is $124.00, about 9.1% above its July 28 closing price of $113.61
The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 20 three months ago
Reuters Recommended Reads
July 29 - Entergy misses second-quarter profit estimates as costs weigh
July 28 - DTE Energy Q2 net income rises; maintains 2026 operating EPS guidance
July 28 - FirstEnergy Corp beats Q2 revenue estimates, reaffirms 2026 outlook
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street -- WSJ
NASDAQ TRADE HALT CONTINUES <EFTY.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 03:28 AM